# Minimally Invasive Nasal Trabeculostomy - Performance and Safety Evaluation Study

> **NCT05638906** · NA · COMPLETED · sponsor: **Sanoculis Ltd** · enrollment: 71 (actual)

## Conditions studied

- This Study is Obtained Under Inclusion/ Exclusion Criteria

## Interventions

- **DEVICE:** MINT

## Key facts

- **NCT ID:** NCT05638906
- **Lead sponsor:** Sanoculis Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-11
- **Primary completion:** 2023-11-28
- **Final completion:** 2023-12-04
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05638906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05638906, "Minimally Invasive Nasal Trabeculostomy - Performance and Safety Evaluation Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05638906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*